Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

Haploidentical hematopoietic cell transplantation (HCT) with posttransplant cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar overall survival (OS) to HLA-matched unrelated donor (MUD) HCT with conventional prophylaxis. Given the prognostic implications of donor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rohtesh S., Marin, David, Alousi, Amin, Kanakry, Christopher G., Champlin, Richard E., Rezvani, Katayoun, Shpall, Elizabeth J., Page, Kristin, Gadalla, Shahinaz M., Weisdorf, Daniel, Kebriaei, Partow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139863/
https://www.ncbi.nlm.nih.gov/pubmed/36630564
http://dx.doi.org/10.1182/bloodadvances.2022009240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139863/
https://www.ncbi.nlm.nih.gov/pubmed/36630564
http://dx.doi.org/10.1182/bloodadvances.2022009240

Ejemplares similares